ID
26500
Description
Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 General Comments
Keywords
Versions (1)
- 10/18/17 10/18/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 18, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Comments Ropinirole in Parkinson's Disease GSK 101468/196
Comments Ropinirole in Parkinson's Disease GSK 101468/196
- StudyEvent: ODM
Description
General Comments - Enter the comments with reference to Subject Visit Date and Visit Name (e.g. Month 36)
Alias
- UMLS CUI-1
- C0947611
Description
Comment: Subject Visit Date
Data type
date
Measurement units
- dd-mmm-yyyy
Alias
- UMLS CUI [1,1]
- C1320303
- UMLS CUI [1,2]
- C0947611
Description
Visit Name
Data type
text
Alias
- UMLS CUI [1]
- C2826704
Description
Comment
Data type
text
Alias
- UMLS CUI [1]
- C0947611
Similar models
Comments Ropinirole in Parkinson's Disease GSK 101468/196
- StudyEvent: ODM
C0947611 (UMLS CUI [1,2])